Mail

Australia markets closed

ALL ORDS
7,235.50
-14.20(-0.20%)
AUD/USD
0.6408
-0.0029(-0.44%)
ASX 200
7,033.20
-15.40(-0.22%)
OIL
91.28
+0.49(+0.54%)
GOLD
1,858.10
-8.00(-0.43%)
Bitcoin AUD
44,295.43
+1,993.46(+4.71%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

21.83

-0.34

(-1.53%)

At close: 04:00PM EDT

21.83

0.00

(0.00%)

After hours:

06:06PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	3.44B
Enterprise value	3.07B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	9.81
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-7.66

Trading information

Stock price history

Beta (5Y monthly)	1.43
52-week change ³	-24.88%
S&P500 52-week change ³	16.57%
52-week high ³	35.98
52-week low ³	19.85
50-day moving average ³	23.65
200-day moving average ³	28.42

Share statistics

Avg vol (3-month) ³	688.08k
Avg vol (10-day) ³	813.59k
Shares outstanding ⁵	157.49M
Implied shares outstanding ⁶	157.49M
Float ⁸	59.61M
% held by insiders ¹	17.51%
% held by institutions ¹	88.78%
Shares short (14 Sept 2023) ⁴	6.02M
Short ratio (14 Sept 2023) ⁴	10.39
Short % of float (14 Sept 2023) ⁴	13.47%
Short % of shares outstanding (14 Sept 2023) ⁴	3.82%
Shares short (prior month 14 Aug 2023) ⁴	5.08M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 June 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-33.43%
Return on equity (ttm)	-98.73%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-393.47M
Net income avi to common (ttm)	-396.57M
Diluted EPS (ttm)	-2.51
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	736.43M
Total cash per share (mrq)	4.68
Total debt (mrq)	481.44M
Total debt/equity (mrq)	137.36%
Current ratio (mrq)	11.47
Book value per share (mrq)	2.23

Cash flow statement

Operating cash flow (ttm)	-340.13M
Levered free cash flow (ttm)	-203.52M